The current consensus is that the anti-tumor immune response in glioma is largely suppressed by brain-resident microglial cells and bone marrow-derived macrophages, and is mainly promoted by CD8+ T cells (Pinton et al., 2019). This evidence concerns the gene CD8A and central nervous system cancer.